SE0801929L - Förfarande för tillverkning av escitalopram - Google Patents

Förfarande för tillverkning av escitalopram

Info

Publication number
SE0801929L
SE0801929L SE0801929A SE0801929A SE0801929L SE 0801929 L SE0801929 L SE 0801929L SE 0801929 A SE0801929 A SE 0801929A SE 0801929 A SE0801929 A SE 0801929A SE 0801929 L SE0801929 L SE 0801929L
Authority
SE
Sweden
Prior art keywords
escitalopram
procedure
manufacturing
benzonitrile
hydroxybutyl
Prior art date
Application number
SE0801929A
Other languages
English (en)
Other versions
SE533041C2 (sv
Inventor
Carla De Faveri
Florian Anton Martin Huber
Robert James Dancer
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39735675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE0801929(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of SE0801929L publication Critical patent/SE0801929L/sv
Publication of SE533041C2 publication Critical patent/SE533041C2/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/32Separation; Purification; Stabilisation; Use of additives
    • C07C253/34Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/53Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and hydroxy groups bound to the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0801929A 2007-09-11 2008-09-09 Förfarande för tillverkning av escitalopram SE533041C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200701314 2007-09-11

Publications (2)

Publication Number Publication Date
SE0801929L true SE0801929L (sv) 2009-03-12
SE533041C2 SE533041C2 (sv) 2010-06-15

Family

ID=39735675

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0801929A SE533041C2 (sv) 2007-09-11 2008-09-09 Förfarande för tillverkning av escitalopram

Country Status (52)

Country Link
EP (2) EP2061753B1 (sv)
JP (1) JP4966933B2 (sv)
KR (1) KR101054224B1 (sv)
CN (1) CN101386583A (sv)
AR (2) AR068174A1 (sv)
AT (2) ATE518829T1 (sv)
AU (1) AU2008212055C1 (sv)
BE (1) BE1017548A6 (sv)
BG (1) BG110206A (sv)
BR (1) BRPI0804121B1 (sv)
CA (1) CA2638499C (sv)
CH (1) CH697885B1 (sv)
CL (1) CL2008002686A1 (sv)
CO (1) CO6140012A1 (sv)
CY (2) CY2600B1 (sv)
CZ (1) CZ2008537A3 (sv)
DE (1) DE102008046530A1 (sv)
DK (2) DK2061753T3 (sv)
EA (1) EA012787B1 (sv)
EE (1) EE00864U1 (sv)
ES (2) ES2368294T3 (sv)
FI (1) FI121570B (sv)
FR (1) FR2920766A1 (sv)
GB (1) GB2448848B (sv)
GR (1) GR1006595B (sv)
HR (2) HRP20080425A2 (sv)
HU (1) HUP0800549A2 (sv)
IE (1) IES20080708A2 (sv)
IL (1) IL193845A (sv)
IS (1) IS8758A (sv)
LT (1) LT5577B (sv)
LU (1) LU91479B1 (sv)
LV (1) LV13813B (sv)
ME (1) ME00176B (sv)
MX (1) MX2008011451A (sv)
MY (1) MY144210A (sv)
NL (1) NL2001953C2 (sv)
NO (1) NO20083756L (sv)
NZ (1) NZ570884A (sv)
PL (2) PL386026A1 (sv)
PT (2) PT104169A (sv)
RO (1) RO125301A2 (sv)
RS (2) RS20080401A (sv)
SE (1) SE533041C2 (sv)
SG (1) SG151195A1 (sv)
SI (2) SI22567A2 (sv)
SK (1) SK500302008A3 (sv)
TR (2) TR200806903A2 (sv)
TW (1) TWI391383B (sv)
UA (2) UA43461U (sv)
WO (1) WO2009033488A1 (sv)
ZA (1) ZA200807753B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007012954A1 (en) 2005-07-27 2007-02-01 Aurobindo Pharma Limited An improved process for the preparation of escitalopram
CN102796065A (zh) * 2011-05-27 2012-11-28 江苏豪森医药集团连云港宏创医药有限公司 一种制备光学纯度高的艾司西酞普兰的方法
CN104119240A (zh) * 2013-04-23 2014-10-29 中国人民解放军军事医学科学院毒物药物研究所 (S)-(-)-α-甲胺基苯丙酮的制备方法
CN103497145B (zh) * 2013-10-10 2016-01-27 南昌大学 一种光学纯多奈哌齐的制备工艺
CN104119248A (zh) * 2014-08-08 2014-10-29 广东东阳光药业有限公司 S-西酞普兰的制备方法
WO2016074225A1 (zh) * 2014-11-14 2016-05-19 浙江华海药业股份有限公司 一种拆分西酞普兰中间体5-氰二醇的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
AR034612A1 (es) 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
AR034759A1 (es) * 2001-07-13 2004-03-17 Lundbeck & Co As H Metodo para la preparacion de escitalopram
IS7239A (is) * 2001-12-14 2004-04-29 H. Lundbeck A/S Aðferð til framleiðslu á essítalóprami
WO2004056754A1 (en) 2002-12-23 2004-07-08 H. Lundbeck A/S A process for the preparation of racemic citalopram diol and/or s- or r- citalopram diols and the use of such diols for the preparation of racemic citalopram, r-citalopram and/or s-citalopram
AU2003242990A1 (en) * 2003-01-17 2004-08-13 Pulla Reddy Muddasani Processes for the preparation of escitalopram and its precursor
US20090018351A1 (en) * 2003-11-12 2009-01-15 Dr. Reddy's Laboratories, Inc. Preparation of escitalopram
WO2006106531A1 (en) * 2005-04-04 2006-10-12 Jubilant Organosys Ltd Process for the preparation of escitalopram or its acid addition salts
WO2007012954A1 (en) * 2005-07-27 2007-02-01 Aurobindo Pharma Limited An improved process for the preparation of escitalopram

Also Published As

Publication number Publication date
EA012787B1 (ru) 2009-12-30
ZA200807753B (en) 2009-04-29
GB2448848B (en) 2011-01-26
MEP10108A (en) 2010-10-10
SI22567A2 (sl) 2008-12-31
PL2061753T3 (pl) 2011-12-30
EA200801797A3 (ru) 2009-02-27
CZ2008537A3 (cs) 2009-03-18
HU0800549D0 (en) 2008-10-28
CY1111924T1 (el) 2015-11-04
CA2638499C (en) 2010-09-28
NZ570884A (en) 2010-03-26
KR20090027185A (ko) 2009-03-16
TR200806903A2 (tr) 2009-03-23
AU2008212055A1 (en) 2009-03-26
MY144210A (en) 2011-08-15
EP2061753B1 (en) 2011-08-03
UA43461U (uk) 2009-08-25
KR101054224B1 (ko) 2011-08-08
GR20080100581A (el) 2009-04-30
CN101386583A (zh) 2009-03-18
ME00176B (me) 2011-02-10
BRPI0804121A2 (pt) 2009-09-29
IL193845A (en) 2011-03-31
GB2448848A (en) 2008-10-29
JP2009149600A (ja) 2009-07-09
ES2368294T3 (es) 2011-11-16
TW200906814A (en) 2009-02-16
CL2008002686A1 (es) 2009-01-02
JP4966933B2 (ja) 2012-07-04
PT2061753E (pt) 2011-09-14
AT10984U1 (de) 2010-02-15
CY2600B1 (en) 2010-03-03
MX2008011451A (es) 2009-03-10
UA41919U (uk) 2009-06-10
NO20083756L (no) 2009-03-12
PT104169A (pt) 2009-02-02
AU2008212055C1 (en) 2011-06-02
BRPI0804121A8 (pt) 2021-04-13
GR1006595B (el) 2009-11-16
WO2009033488A1 (en) 2009-03-19
TWI391383B (zh) 2013-04-01
ES2334875B1 (es) 2010-10-27
EP2061753A1 (en) 2009-05-27
NL2001953A1 (nl) 2008-12-22
BRPI0804121B1 (pt) 2022-04-12
EE00864U1 (et) 2009-10-15
TR200907629A2 (tr) 2009-11-23
IES20080708A2 (en) 2009-03-18
RS51909B (en) 2012-02-29
SI2061753T1 (sl) 2011-10-28
NL2001953C2 (en) 2009-05-07
SE533041C2 (sv) 2010-06-15
CH697885B1 (de) 2009-03-13
AU2008212055B2 (en) 2010-08-12
BE1017548A6 (fr) 2008-11-04
FI20085807A (sv) 2009-03-12
IS8758A (is) 2009-03-12
DE102008046530A1 (de) 2009-03-19
EA200801797A2 (ru) 2008-12-30
DK177075B1 (da) 2011-06-14
BG110206A (en) 2009-03-31
RS20080401A (en) 2010-03-02
DK2061753T3 (da) 2011-09-26
SG151195A1 (en) 2009-04-30
FI20085807A0 (sv) 2008-08-29
LT5577B (lt) 2009-06-25
AR108885A2 (es) 2018-10-03
DK200801265A (en) 2009-03-12
GB0815773D0 (en) 2008-10-08
RO125301A2 (ro) 2010-03-30
ATE518829T1 (de) 2011-08-15
LV13813B (en) 2008-11-20
SK500302008A3 (sk) 2009-04-06
EP2397461A1 (en) 2011-12-21
CO6140012A1 (es) 2010-03-19
LT2008068A (en) 2009-03-25
HUP0800549A2 (en) 2009-03-02
ES2334875A1 (es) 2010-03-16
HRP20110636T1 (hr) 2011-10-31
FI121570B (sv) 2011-01-14
HRP20080425A2 (hr) 2010-04-30
FR2920766A1 (fr) 2009-03-13
CA2638499A1 (en) 2008-11-21
AR068174A1 (es) 2009-11-11
LU91479B1 (fr) 2010-03-11
PL386026A1 (pl) 2009-02-16

Similar Documents

Publication Publication Date Title
AR108885A2 (es) Método para la elaboración de escitalopram
DE602004029724D1 (de) Verfahren zur Herstellung von organischen Verbindungen aus Glycerol, stammend aus nachwachsenden Rohstoffen
RS51341B (en) INTERMEDIATE COMPOUNDS FOR THE TRANS-5-CHLOR-2-METHYL-2,3A, 12B-TETRAHYDRO-1H-DIBENZE [2,3; 6,7] OXEPINO [4,5-C] Pyrrole
AR029598A1 (es) Metodo para la preparacion de citalopram
ATE327972T1 (de) Verfahren zur herstellung von optisch-reinen (r)- und (s)- didesmethylsibutramin
DE602005017194D1 (de) Verfahren zur herstellung von carvedilol und seinen enantiomeren
ATE402171T1 (de) Verfahren zur herstellung enantiomerer imidazolverbindungen
WO2010056633A8 (en) 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
DE602006014001D1 (de) Herstellung von 2-aminothiazol-5-carbonsäurederivaten
HK1099759A1 (en) A process for the resolution of nefopam
ATE368661T1 (de) Verfahren zur herstellung von 5-(4-fluorphenyl)-1- 2-((2r,4r)-4-hydroxy-6-oxo etrahydropyran-2- yl)ethylö-2-isopropyl-4-phenyl-1h-pyrrol-3- carbonsäurephenylamid
DE602005006770D1 (de) Chemisch-enzymatisches verfahren zur herstellung von escitalopram
DK1988086T3 (da) Fremgangsmåde til opløsning af citalopram via dets (S)-berigede citalopramtartratforbindelse
ATE387423T1 (de) Verfahren zur herstellung der enantiomeren formen von 2,3-diaminopropionsäurederivaten
WO2006127331A3 (en) Conversion process for 2,3-benzodiazepine enantiomers
MX2010005026A (es) Metodo para resolucion de una mezcla de isomeros opticos de pinocembrina. especialmente un racemato de pinocembrina.
ATE550422T1 (de) Verfahren zur herstellung von mycophenolsäure mit penicillium arenicola bicc7673
ITRM20010318A1 (it) Procedimento per la produzione di composti organici perfluorurati mediante florurazione elettrochimica.
BR0117107B1 (pt) composição compreendendo composto de crescimento orgánico à base de carvão, bem como método para melhorar a produção de plantas de cultivo.
DE602005025912D1 (de) Neues verfahren zur herstellung von 3-ä5'-(3,4-bis-hydroxymethyl-benzyloxy)-2'- ethyl-2-propyl-biphenyl-4-ylü-penta-3-ol
ATE454374T1 (de) Verfahren zur herstellung von 1,5- diphenylpyrazolcarbonsäurederivaten

Legal Events

Date Code Title Description
WITD Patent withdrawn according to par. 54 patents act
NUG Patent has lapsed